首页> 外文期刊>Medicine. >The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China
【24h】

The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China

机译:幽门螺杆菌的年龄与抗生素耐药性的关联:在浙江省嘉兴市的一项研究

获取原文
获取原文并翻译 | 示例
           

摘要

The antibiotic resistance of Helicobacter pylori (H pylori) is steadily increasing worldwide, resulting in the low efficiency of the current therapeutic approaches for eradication. In this study, we investigated the relationship between antibiotic resistances, the year of sample collection, and the ages of the infected individuals.A total of 29,034 gastric mucosa biopsy samples were randomly collected from January 1, 2009 to December 9, 2014 in Jiaxing City, Zhejiang Province, China. An antibiotic susceptibility testing was determined using an agar-dilution method. The statistical significance was tested using the chi-squared ((2)) test.A total of 9687 strains were isolated. The resistance rate to clarithromycin, levofloxacin, and metronidazole were 17.76%, 19.66%, and 95.5%, respectively. Resistance was rare against amoxicillin, gentamicin, and furazolidone. The metronidazole resistance rate stayed at a consistently high level. In contrast, the resistance rates of clarithromycin and levofloxacin increased rapidly from 2009 to 2011, gradually decreased from 2012 to 2013, and then increased again in 2014. Although patients ages 31 to 50 and 71 to 80 years had lower infection rates of H pylori, they also had higher resistance rates to clarithromycin and levofloxacin. The highest antibiotic resistance rate was observed in patients' ages 71 to 80 years old. Younger patients (below 30 years old) had a lower resistance to levofloxacin. Patients' ages 51 to 60 years old may thus represent an important category for the future study of H pylori infection.Age plays a key element in H pylori resistance to clarithromycin and levofloxacin. It is therefore necessary to consider individualized therapy for the optimized treatment of H pylori-infected patients.
机译:幽门螺杆菌(H pylori)的抗生素耐药性在世界范围内稳定增长,导致当前根除的治疗方法效率低下。本研究调查了2009年1月1日至2014年12月9日期间随机采集的29,034例胃黏膜活检样本与抗生素耐药性,样本采集年份和被感染者年龄之间的关系。中国浙江省。使用琼脂稀释法确定抗生素敏感性测试。使用卡方检验((2))检验统计学意义。共分离到9687株。对克拉霉素,左氧氟沙星和甲硝唑的耐药率分别为17.76%,19.66%和95.5%。对阿莫西林,庆大霉素和呋喃唑酮的耐药性很少。甲硝唑耐药率始终保持在较高水平。相比之下,克拉霉素和左氧氟沙星的耐药率从2009年到2011年迅速上升,从2012年到2013年逐渐下降,然后在2014年再次上升。尽管年龄在31至50岁和71至80岁的患者的幽门螺杆菌感染率较低,他们对克拉霉素和左氧氟沙星的耐药率也更高。在71至80岁的患者中观察到最高的抗生素耐药率。年轻的患者(30岁以下)对左氧氟沙星的抵抗力较低。因此,年龄在51至60岁之间的患者可能代表了未来幽门螺杆菌感染研究的重要类别。年龄是幽门螺杆菌对克拉霉素和左氧氟沙星耐药的关键因素。因此,有必要考虑个体化治疗以优化幽门螺杆菌感染患者的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号